Candriam S.C.A. Legend Biotech Corp Transaction History
Candriam S.C.A.
- $16.8 Billion
- Q2 2025
A detailed history of Candriam S.C.A. transactions in Legend Biotech Corp stock. As of the latest transaction made, Candriam S.C.A. holds 261,815 shares of LEGN stock, worth $8.41 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
261,815
Previous 221,832
18.02%
Holding current value
$8.41 Million
Previous $7.53 Million
23.45%
% of portfolio
0.06%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding LEGN
# of Institutions
239Shares Held
59.7MCall Options Held
591KPut Options Held
381K-
Westfield Capital Management CO LP Boston, MA6.92MShares$222 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$192 Million8.76% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$184 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.77MShares$121 Million4.61% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$95.2 Million2.42% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.38B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...